Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tomoki Naoe is active.

Publication


Featured researches published by Tomoki Naoe.


Blood | 2007

A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARα transcript after consolidation therapy: The Japan Adult Leukemia Study Group (JALSG) APL97 study

Norio Asou; Yuji Kishimoto; Hitoshi Kiyoi; Masaya Okada; Yasukazu Kawai; Motohiro Tsuzuki; Kentaro Horikawa; Mitsuhiro Matsuda; Katsuji Shinagawa; Tohru Kobayashi; Shigeki Ohtake; Miki Nishimura; Masatomo Takahashi; Fumiharu Yagasaki; Akihiro Takeshita; Yukihiko Kimura; Masako Iwanaga; Tomoki Naoe; Ryuzo Ohno


Archive | 2005

Flt-3 INHIBITOR

Yukimasa Shiotsu; Hiroshi Umehara; Yoshinori Yamashita; Masayo Suzuki; Satoshi Kaneko; Yutaka Kanda; Tomoki Naoe; Hitoshi Kiyoi


Archive | 1999

Method for screening candidate compounds for drug against tumor

Toshio Kitamura; Hitoshi Kiyoi; Tomoki Naoe; Masayuki Towatari


Rinsho Ketsueki | 1995

Efficacy of Early Administration of G-CSF After Intensive Chemotherapy in Acute Leukemia: A Randomized Controlled Trial

Hideo Takeyama; Yamada H; Nobuhiko Emi; Hidehiko Saito; Akihiro Takeshita; Ryuzo Ohno; Hitoshi Yoshida; Tomoki Naoe; Shinichi Kageyama; Shigeru Shirakawa; Yoshihisa Kodera; Noriyuki Hirabayashi; Hiroshi Nishiwaki; Kazuyuki Naito; Masami Hirano; Ryouichi Kato; Masao Tanaka; Kouichirou Nagata; Masakazu Nitta; Yoshihisa Morishita


Archive | 2006

Method for screening candidate compounds for antitumor drug

Hitoshi Kiyoi; Tomoki Naoe; Masayuki Towatari; Toshio Kitamura


Archive | 2017

PHARMACEUTICAL COMPOSITION FOR TREATING FLT3 MUTATION-POSITIVE CANCER, MUTANT FLT3 INHIBITOR AND USES THEREOF

Tomoki Naoe; Hitoshi Kiyoi; Shinji Hagiwara; Masaru Takasaki; Daisuke Hirano; Toshiyuki Nakatani; Takeshi Yamaura


Archive | 2009

-positive acute lymphoblastic leukemia BCR-ABL diagnosed high-quality complete remission for a majority of patients with newly Combination of intensive chemotherapy and imatinib can rapidly induce

Tomoki Naoe; Ryuzo Ohno; Fumiharu Yagasaki; Yasukazu Kawai; Shuichi Miyawaki; Shigeki Ohtake; Itsuro Jinnai; Masayuki Towatari; Masamitsu Yanada; Noriko Usui; Jin Takeuchi; Isamu Sugiura; Makoto Takeuchi


Archive | 2007

Procédé d'identification de médicaments candidats pour le traitement de la leucémie myéloïde aiguë

Tomoki Naoe; Fumihiko Hayakawa; Mitsunori Okamoto


Archive | 2004

Inhibiteurs de la protéine kinase

Yukimasa Shiotsu; Hiroshi Umehara; Fumihiko Kanai; Shinji Nara; Yoshihisa Ohta; Yutaka Kanda; Shiro Akinaga; Tomoki Naoe; Hitoshi Kiyoi; Tomoyuki Nakazato; Satoshi Tashiro


Archive | 2000

Tandem - duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cel

Fumihiko Hayakawa; Masayuki Towatari; Hitoshi Kiyoi; Mitsune Tanimoto; Tadaichi Kitamura; Hirohisa Saito; Tomoki Naoe

Collaboration


Dive into the Tomoki Naoe's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fumiharu Yagasaki

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hidehiko Saito

Fujita Health University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge